Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
5mg |
|
||
10mg |
|
||
50mg |
|
||
Other Sizes |
|
Targets |
HIV-1
|
---|---|
ln Vivo |
Reverse transcriptase-IN-1 (Compound 12z) has a markedly increased oral bioavailability of 16.5% in rats when administered at a dose of 5 mg/kg. Reverse transcriptase-IN-1 has an inherent microsome clearance of 33.2 μL/min/mg proteins in rats. Reverse transcriptase-IN-1 is absorbed at two different doses, with mean residence times (MRTs) of 11.8 hours (5 mg/kg, po) and 11.4 hours (1 mg/kg, iv), according to the PK study and safety evaluation. At a dose of 5 mg/kg, the Cmax of reverse transcriptase-IN-1 is 39.9 ng/mL. Rats used in a single-dose toxicity test for reverse transcriptase-IN-1 exhibit no signs of death, and the animals' body weight did not drop abnormally in the week after an intragastrical dose of 293 mg/kg body weight. According to the aforementioned findings, reverse transcriptase-IN-1 may be a viable oral bioavailable option for studying HIV-1 infection in humans[1].
|
References |
[1]. Han S, et al. Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. ACS Infect Dis. 2019 Oct 24.
|
Molecular Formula |
C25H17N7O2
|
---|---|
Molecular Weight |
447.45
|
CAS # |
2380001-43-2
|
SMILES |
C1(=C(NC2=NC(NC3C=CC(=CC=3)C#N)=NC3C2=CC=CC=3)C(C)=CC(=C1)/C=C/C#N)[N+]([O-])=O
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : 12.5 mg/mL (27.94 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.25 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 1.25 mg/mL (2.79 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.2349 mL | 11.1744 mL | 22.3489 mL | |
5 mM | 0.4470 mL | 2.2349 mL | 4.4698 mL | |
10 mM | 0.2235 mL | 1.1174 mL | 2.2349 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.